[11 December/ Reuters]

Nestle has announced that it has reached an agreement to buy Canadian vitamin maker Atrium Innovations for USD 2.3 billion, increasing its presence in consumer healthcare. Nestle Health Science Head, Greg Behar said the purchase of Atrium, which would have USD 700 million in sales this year, would add to earnings immediately. Atrium had seven factories in the United States, Canada, Europe and Argentina. The purchase of Atrium was expected to close during the first quarter of 2018.